SCHEMBL4924467

SCHEMBL4924467

Cc1cccc(C)c1-c1cccc2c(N)c3c(nc12)CN(C1CC1)C3=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 1/20 0.41
▸ MAPK1 P28482 1/20 0.39
▸ GABRG2 P18507 1/20 0.36
▸ GABRB3 P28472 1/20 0.36
▸ GABRA2 P47869 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ PARP1 P09874 3/20 0.34
▸ PARP2 Q9UGN5 1/20 0.34
▸ MAOA P21397 2/20 0.34
▸ NPY1R P25929 1/20 0.34
▸ NPY5R Q15761 1/20 0.34
▸ GRM5 P41594 1/20 0.33
▸ BMPR1A P36894 1/20 0.33
▸ ACVRL1 P37023 1/20 0.33
▸ ACVR1 Q04771 1/20 0.33
▸ PDE4A P27815 1/20 0.33
▸ TYMS P04818 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ HTR2C P28335 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2662522 0.88 MAPK1 (0.48) MAPK1GABRG2GABRB3GABRA2PARP1
SCHEMBL2669595 0.84 MAPK1 (0.47) MAPK1PARP1PARP2MAOANPY1R
SCHEMBL2661944 0.84 MAPK1 (0.47) MAPK1PARP1MAOANPY1RNPY5R
SCHEMBL2657367 0.84 MTOR (0.38) MAPK1BMPR1AACVRL1ACVR1PDE4A
SCHEMBL2656990 0.84 MAPK1 (0.39) MAPK1PARP2MAOANPY1RNPY5R
SCHEMBL2661432 0.84 MAPK1 (0.34) MAPK1PARP2MAOANPY1RNPY5R
SCHEMBL2662121 0.84 MAPK1 (0.34) MAPK1PARP2MAOANPY1RNPY5R
SCHEMBL4922297 0.84 NPY1R (0.43) MAPK1GABRG2GABRB3GABRA2MEN1
SCHEMBL2669534 0.84 LCK (0.46) BMPR1AACVRL1ACVR1
SCHEMBL2661690 0.83 GABRA1 (0.44) MAPK1GABRG2GABRB3GABRA2MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080318943-A1 Compounds and Uses Thereof - 848 ASTRAZENECA AB (SE) 2008-12-25 — — US claimed
US-20080318943-A1 Compounds and Uses Thereof - 848 ASTRAZENECA AB (SE) 2008-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318943-A1 Compounds and Uses Thereof - 848 COMT, BACE1, BDNF HRH4 167/4885MAPK1 3191/4885GABRG2 592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback